Immunogen reported $-57790000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Amgen AMGN:US USD 2.54B 364M
Astellas Pharma 4503:JP JPY 59.76B 29.04B
AstraZeneca AZN:LN USD 2.29B 796M
Bluebird Bio BLUE:US USD -76513000 16.99M
Eli Lilly And LLY:US USD 2.04B 38.3M
Emergent Biosolutions EBS:US USD 6.6M 54.9M
Exelixis EXEL:US USD -31427000 123.47M
Halozyme Therapeutics HALO:US USD 70.79M 2.92M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Immunogen IMGN:US USD -57790000 19.96M
Intrexon XON:US USD -22168000 14.47M
Karyopharm Therapeutics KPTI:US USD -38433000 2.15M
Macrogenics MGNX:US USD 12.8M 37.61M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Novartis NVS:US USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Roche Holding ROG:VX 8.85B 3.26B